Clinical Trial Update: Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating oxytocin in combination with social interventions for schizophrenia and schizoaffective disorder; the trial status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Oxytocin + Non Specific Counselling, Oxytocin + Social Skills Training | Phase 2 | Status: UNKNOWN